My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
GPT Infraprojects gains after winning order
Feb 20,2017

The announcement was made after market hours on 17 February 2017.

Meanwhile, the BSE Sensex was up 62.86 points, or 0.22%, to 28,531.61.

On the BSE, so far 4,838 shares were traded in the counter, compared with average daily volumes of 5,943 shares in the past one quarter. The stock had hit a high of Rs 256.65 and a low of Rs 248 so far during the day.

The stock hit a record high of Rs 299.85 on 3 October 2016. The stock hit a 52-week low of Rs 186.50 on 29 April 2016. The stock had underperformed the market over the past 30 days till 17 February 2017, rising 3.75% compared with the 4.25% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 8.26% as against Sensexs 8.87% rise.

The small-cap company has equity capital of Rs 14.54 crore. Face value per share is Rs 10.

GPT Infraprojects has bagged orders valued at Rs 64 crore from Rail Vikas Nigam. The order is for construction of a major bridge over river Chanderbagha in Uttarakhand. The project has to be completed within 18 months. The current order book of GPT Infraprojects stands at Rs 1925 crore, including cumulative order inflow of Rs 703 crore in the current financial year.

On a consolidated basis, net profit of GPT Infraprojects declined 14.45% to Rs 3.02 crore on 13.81% decline in net sales to Rs 106.15 crore in Q3 December 2016 over Q3 December 2015.

GPT Infraprojects is an infrastructure company based out of Kolkata.

Powered by Capital Market - Live News

GE Shipping gains after delivery of supply vessel
Feb 20,2017

The announcement was made after market hours on Friday, 17 February 2017.

Meanwhile, the S&P BSE Sensex was up 46.74 points or 0.16% at 28,515.49.

On the BSE, 6,108 shares were traded on the counter so far as against the average daily volumes of 7,685 shares in the past one quarter. The stock had hit a high of Rs 369.25 and a low of Rs 360.95 so far during the day.

The stock had hit a 52-week high of Rs 410.40 on 20 January 2017 and a 52-week low of Rs 275 on 2 March 2016. The stock had underperformed the market over the past one month till 17 February 2017, sliding 7.15% compared with the Sensexs 4.53% rise. The scrip had also underperformed the market over the past one quarter, declining 0.08% as against the Sensexs 8.54% rise.

The mid-cap company has equity capital of Rs 150.78 crore. Face value per share is Rs 10.

Great Eastern Shipping Company (GE Shipping) said that its wholly owned subsidiary Greatship (India) has sold and delivered its 1999 built platform supply vessel (PSV) Greatship Disha to the buyers.

On a consolidated basis, net profit of GE Shipping fell 33.4% to Rs 238.36 crore on 23.2% decline in net sales to Rs 738.91 crore in Q3 December 2016 over Q3 December 2015.

GE Shipping has two main business: shipping and offshore. The shipping business is involved in transportation of crude oil, petroleum products, gas and dry bulk commodities. The offshore business services to the oil companies in carrying out offshore exploration and production activities, through its subsidiary Greatship (India).

Powered by Capital Market - Live News

Maruti Suzuki gains after good smart hybrid vehicles sales
Feb 20,2017

The announcement was made during trading hours today, 20 February 2017.

Meanwhile, the BSE Sensex was up 26.47 points, or 0.09%, to 28,495.22.

On the BSE, so far 18,000 shares were traded in the counter, compared with average daily volumes of 60,860 shares in the past one quarter. The stock had hit a high of Rs 6,073.20 and a low of Rs 5,915.65 so far during the day.

The stock hit a record high of Rs 6,230.30 on 8 February 2017. The stock hit a 52-week low of Rs 3,202.10 on 29 February 2016. The stock had outperformed the market over the past 30 days till 17 February 2017, rising 4.81% compared with the 4.25% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 20.74% as against Sensexs 8.87% rise.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

Maruti Suzuki India announced that its smart hybrid vehicles n++ Ciaz SHVS and Ertiga SHVS n++ have crossed cumulative sales of 1 lakh units this month. This marks the success of Maruti Suzukis efforts in hybrid and electric mobility in India.

Introduction of technologies like smart hybrid can only create a significant positive impact if they are made available to a larger section of customers. With this as a premise, Maruti Suzuki introduced Indias first smart hybrid vehicle, Ciaz SHVS on 1 September 2015, it subsequently introduced the technology in Ertiga Diesel in October 2015.

Smart Hybrid Vehicle by Suzuki (SHVS) is a technology which uses an integrated starter generator (ISG) and an advanced high capacity battery to supplement the engines power. SHVS technology makes it more efficient than the conventional set-up and saves energy while decelerating/braking.

Ciaz and Ertiga Smart Hybrid participate in Government of Indias FAME lndia scheme, which aims to promote faster adoption and manufacturing of hybrid and electric vehicles in India.

Ciaz SHVS, with a certified fuel efficiency of 28.09 kilometer per liter (km/I), tops the mileage chart in India. Ertiga SHVS, with 24.52 km/I, has set new bench marks in fuel efficiency in its category. SHVS equipped vehicles account for over 60% of volume of the two models.

Maruti Suzuki Indias net profit rose 47.5% to Rs 1744.50 crore on 12.4% growth in net sales to Rs 16623.60 crore in Q3 December 2016 over Q3 December 2015.

Maruti Suzuki India is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti (as per the shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Mangalam Drugs jumps after WHO-Geneva inspects unit-2 facility
Feb 20,2017

The announcement was made after market hours on Friday, 17 February 2017.

Meanwhile, the BSE Sensex was up 46.69 points, or 0.16%, to 28,515.44.

On the BSE, so far 46,000 shares were traded in the counter, compared with average daily volumes of 20,918 shares in the past one quarter. The stock had hit a high of Rs 164.90 and a low of Rs 156.50 so far during the day.

The stock hit a 52-week high of Rs 296.20 on 16 March 2016. The stock hit a 52-week low of Rs 122.90 on 22 November 2016. The stock had underperformed the market over the past 30 days till 17 February 2017, falling 6.59% compared with the 4.25% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 9.69% as against Sensexs 8.87% rise.

The small-cap company has equity capital of Rs 15.83 crore. Face value per share is Rs 10.

Mangalam Drugs & Organics added that it will respond to the same within stipulated time after the receipt of audit report. The company believes that the audit was successful.

Net profit of Mangalam Drugs and Organics rose 63.16% to Rs 6.20 crore on 6.6% decline in net sales to Rs 76.90 crore in Q3 December 2016 over Q3 December 2015.

Mangalam Drugs & Organics manufactures active pharma ingredients (APIs), intermediates and specialty chemicals.

Powered by Capital Market - Live News

TCS gains ahead of board meeting to consider share buyback
Feb 20,2017

Meanwhile, the S&P BSE Sensex was up 4.10 points or 0.01% at 28,472.85.

On the BSE, 17,000 shares were traded on the counter so far as against the average daily volumes of 96,194 shares in the past one quarter. The stock had hit a high of Rs 2,448 and a low of Rs 2,412 so far during the day.

The stock had hit a 52-week high of Rs 2,740 on 16 August 2016 and a 52-week low of Rs 2,054.70 on 15 November 2016. The stock had outperformed the market over the past one month till 17 February 2017, advancing 5.73% compared with the Sensexs 4.53% rise. The scrip had also outperformed the market over the past one quarter, gaining 12.42% as against the Sensexs 8.54% rise.

The large-cap company has equity capital of Rs 197.04 crore. Face value per share is Re 1.

On a consolidated basis, TCS net profit rose 3.20% to Rs 6814 crore on 1.54% increase in net sales to Rs 29735 crore in Q3 December 2016 over Q2 September 2016.

TCS is an IT services, consulting and business solutions organization.

Powered by Capital Market - Live News

Amtek Auto jumps on plan to issue equity shares
Feb 20,2017

The announcement was made after market hours on Friday, 17 February 2017.

Meanwhile, the BSE Sensex was down 36.31 points, or 0.13%, to 28,432.44.

On the BSE, so far 1.11 lakh shares were traded in the counter, compared with average daily volumes of 4.19 lakh shares in the past one quarter. The stock had hit a high of Rs 35.70 and a low of Rs 34.85 so far during the day.

The stock hit a 52-week high of Rs 56.20 on 26 July 2016. The stock hit a 52-week low of Rs 28 on 29 February 2016. The stock had underperformed the market over the past 30 days till 17 February 2017, falling 2.29% compared with the 4.25% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 0.44% as against Sensexs 8.87% rise.

The small-cap company has equity capital of Rs 44.95 crore. Face value per share is Rs 2.

Amtek Auto said that the proposal to issue equity shares is subject to the approval of the shareholders of the company in its general meeting.

Amtek Auto reported a net loss of Rs 241.56 crore in Q3 December 2016 compared with net loss of Rs 175.36 crore in Q3 December 2015. Net sales fell 46.8% to Rs 438.40 crore in Q3 December 2016 over Q3 December 2015.

Amtek Auto is an integrated component manufacturer.

Powered by Capital Market - Live News

Kotak Mahindra Bank gains, Axis Bank drops in early trade
Feb 20,2017

Kotak Mahindra Bank (up 0.54% at Rs 800.50) edged higher. Axis Bank (down 0.04% at Rs 488.80) edged lower.

Meanwhile, the S&P BSE Sensex was down 27.34 points or 0.1% at 28,441.41.

Kotak Mahindra Bank in its clarification issued to the stock exchanges with respect to recent news article in media titled Kotak Mahindra, Axis Bank shares up on merger buzz said that it does not comment on speculation. The bank undertakes to comply with all its disclosure obligations, it said. The announcement was made after market hours on Friday, 17 February 2017.

Meanwhile, media reports quoted Axis Bank CEO Shikha Sharma as saying that there is no truth in merger reports of Axis Bank with Kotak Mahindra Bank.

Axis Bank is one of the biggest private sector banks in India. The banks net profit dropped 73.4% to Rs 579.57 crore on 15.7% growth in total income to Rs 14501.21 crore in Q3 December 2016 over Q3 December 2015.

Kotak Mahindra Bank is one of the leading private sector banks in India. The banks net profit rose 38.6% to Rs 879.76 crore on 11% growth in total income to Rs 5377.83 crore in Q3 December 2016 over Q3 December 2015.

Powered by Capital Market - Live News

Indian Hotels drops on profit booking
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 139.25 points, or 0.49%, to 28,440.52

On BSE, so far 58,000 shares were traded in the counter, compared with average daily volume of 85,789 shares in the past one quarter. The stock hit a high of Rs 120.95 and a low of Rs 115.90 so far during the day. The stock hit a 52-week high of Rs 143 on 14 July 2016. The stock hit a 52-week low of Rs 88.80 on 21 November 2016. The stock had outperformed the market over the past 30 days till 16 February 2017, rising 12.86% compared with the 3.83% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 32.07% as against Sensexs 8.23% rise.

The large-cap company has an equity capital of Rs 98.93 crore. Face value per share is Re 1.

Indian Hotels Companys consolidated net profit rose 598.57% to Rs 92.98 crore on 2.94% fall in total income to Rs 1151.61 crore in Q3 December 2016 over Q3 December 2015.

Indian Hotels Company (IHCL) and its subsidiaries, collectively known as Taj Group, are engaged in the business of owning, operating & managing hotels, palaces and resorts. IHCL is a Tata group company.

Powered by Capital Market - Live News

HOEC slips on profit booking
Feb 17,2017

Meanwhile, the BSE Sensex was up 184.80 points, or 0.65%, to 28,486.07.

On the BSE, so far 2.38 lakh shares were traded in the counter, compared with average daily volumes of 3.57 lakh shares in the past one quarter. The stock had hit a high of Rs 76.75 and a low of Rs 74.25 so far during the day.

The stock hit a 52-week high of Rs 78.90 on 16 February 2017. The stock hit a 52-week low of Rs 26.55 on 29 February 2016.

The small-cap company has equity capital of Rs 130.49 crore. Face value per share is Rs 10.

Shares of Hindustan Oil Exploration Company (HOEC) rose 8.14% in three trading sessions to settle at Rs 75.70 yesterday, 16 February 2017, from its close of Rs 70 on 13 February 2017.

Shares of HOEC rose 2.37% to end at Rs 75.70 yesterday, 16 February 2017, after the company said it secured two contracts in consortia with Oil India, Prize Petroleum and other private company by the Government of India in the recently concluded bidding for Discovered Small Field Bids Round (DSF 2016). The announcement was made during market hours yesterday, 16 February 2017.

Hindustan Oil Exploration Company (HOEC) reported 30.22% rise in net profit to Rs 4.18 crore on 10.1% rise in net sales to Rs 5.49 crore in Q3 December 2016 over Q3 December 2015.

HOEC has a wholly owned subsidiary, HOEC Bardahl India, engaged in marketing of high performance fuel/engine additives.

Powered by Capital Market - Live News

Repco Home Finance jumps on bargain hunting
Feb 17,2017

Meanwhile, the BSE Sensex was up 186.14 points, or 0.66%, to 28,487.41.

On the BSE, so far 19,000 shares were traded in the counter, compared with average daily volumes of 26,785 shares in the past one quarter. The stock had hit a high of Rs 665.25 and a low of Rs 635.10 so far during the day.

The stock hit a 52-week high of Rs 891.30 on 6 September 2016. The stock hit a 52-week low of Rs 499.50 on 20 December 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 0.89% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 13.19% as against Sensexs 8.23% rise.

The mid-cap company has equity capital of Rs 62.56 crore. Face value per share is Rs 10.

Shares of Repco Home Finance fell 13.06% in three trading sessions to settle at Rs 632.80 yesterday, 16 February 2017, from its close of Rs 727.90 on 13 February 2017.

Net profit of Repco Home Finance rose 20.4% to Rs 46.44 crore on 18.7% rise in operating income to Rs 260.19 crore in Q3 December 2016 over Q3 December 2015.

Repco Home Finance (RHFL) is a professionally managed housing finance company headquartered in Chennai, Tamil Nadu. As at the end of March 2016, RHFL is operating through 120 branches and 31 satellite centres in Tamil Nadu, Andhra Pradesh, Jharkhand, Kerala, Karnataka, Maharashtra, Madhya Pradesh, Gujarat, Odisha, West Bengal and Puducherry.

Powered by Capital Market - Live News

Finolex Cables gains after fund buying
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 190.73 points, or 0.67%, to 28,495.98

On BSE, so far 22,000 shares were traded in the counter, compared with an average volume of 22,697 shares in the past one quarter. The stock hit a high of Rs 451.55 and a low of Rs 443.05 so far during the day.

The stock hit a 52-week high of Rs 472.15 on 13 February 2017. The stock hit a 52-week low of Rs 224.75 on 17 February 2016. The stock had outperformed the market over the past 30 days till 16 February 2017, rising 5.16% compared with the 3.83% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 12.5% as against Sensexs 8.23% rise.

The small-cap company has an equity capital of Rs 30.59 crore. Face value per share is Rs 2.

Armor Capital Partners LP sold 9.34 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on BSE yesterday, 16 February 2017.

Separately, SBI Mutual Fund bought 9.40 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on NSE yesterday, 16 February 2017. Armor Capital Partners LP sold 9.35 lakh shares of Finolex Cables at Rs 437 per share in a bulk deal on NSE yesterday, 16 February 2017.

Finolex Cables net profit rose 37.77% to Rs 68.43 crore on 11.21% rise in total income to Rs 692.26 crore in Q3 December 2016 over Q3 December 2015.

Finolex Cables, the flagship company of the Finolex Group, is Indias largest and leading manufacturer of electrical and telecommunication cables.

Powered by Capital Market - Live News

Cipla gains after launching Hepatitis B vaccine in India
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 203.30 points, or 0.72%, to 28,504.57.

On the BSE, so far 1.44 lakh shares were traded in the counter, compared with average daily volumes of 97,473 shares in the past one quarter. The stock had hit a high of Rs 596.25 and a low of Rs 581.70 so far during the day.

The stock hit a 52-week high of Rs 621.90 on 6 February 2017. The stock hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, rising 0.31% compared with the 3.83% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 6.12% as against Sensexs 8.23% rise.

The large-cap pharmaceutical company has equity capital of Rs 160.89 crore. Face value per share is Rs 2.

Cipla announced that it has launched adult Hepatitis B vaccine in India. Under a co-exclusive agreement with Serum Institute of India (SII), Cipla will market the vaccine for adults while SII will market it for adults and children.

Serum Institute of India is the worlds second largest vaccine manufacturer in number of doses manufactured and supplied to more than 140 countries.

Umang Vohra, MD and Global CEO Cipla said that this agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Ciplas strong marketing network and reach will ensure maximum accessibility of the vaccines in India.

In India, around 40 million people are chronically infected with Hepatitis B. This infection is responsible for 70% of chronic Hepatitis and 80% of liver cirrhosis. Hepatitis B is spread through contact with an infected persons blood and body fluids. At risk are all those who are not vaccinated against the infection. Since 2002 the Hepatitis B vaccine has been a part of Indias Universal Immunization Programme. This vaccine is able to protect 95% of recipients from developing chronic Hepatitis B. The vaccine is given in three doses that include one after the first month of the first dose and the second after 6 months post the first dose. The vaccine can protect the recipient from this infection for decades. In addition, it is expected to bring down the number of cases of liver cirrhosis and liver cancer.

Ciplas consolidated net profit rose 43.85% to Rs 374.83 crore on 15.64% rise in net sales to Rs 3550.02 crore in Q3 December 2016 over Q3 December 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1000 products across wide range of therapeutic categories.

Powered by Capital Market - Live News

Karur Vysya Bank turns volatile after huge bulk deal
Feb 17,2017

Meanwhile, the S&P BSE Sensex was up 167.37 points, or 0.59%, to 28,468.64

On BSE, so far 2.42 crore shares were traded in the counter, compared with average daily volume of 67,396 shares in the past one quarter. The stock saw high intraday volatility. The stock hit a high of Rs 94.80 and a low of Rs 91 so far during the day. The stock hit a 52-week high of Rs 108.28 on 11 July 2016. The stock hit a 52-week low of Rs 78.78 on 29 February 2016.

The mid-cap private sector bank has equity capital of Rs 121.86 crore. Face value per share is Rs 2.

Karur Vysya Banks net profit dropped 24.26% to Rs 115.76 crore on 3.68% rise in total income to Rs 1581.26 crore in Q3 December 2016 over Q3 December 2015.

Karur Vysya Bank has 667 branches and 1655 ATMs as on 31 March 2016.

Powered by Capital Market - Live News

Venus Remedies spurts on QIP plan
Feb 17,2017

The announcement was made during trading hours today, 17 February 2017.

Meanwhile, the BSE Sensex was up 166.87 points, or 0.59%, to 28,468.14.

On the BSE, so far 1.67 lakh shares were traded in the counter, compared with average daily volumes of 31,821 shares in the past one quarter. The stock had hit a high of Rs 106.40 and a low of Rs 95 so far during the day.

The stock hit a 52-week high of Rs 142.80 on 5 October 2016. The stock hit a 52-week low of Rs 65 on 1 June 2016. The stock had underperformed the market over the past 30 days till 16 February 2017, falling 9.07% compared with the 3.83% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 11.54% as against Sensexs 8.23% rise.

The small-cap company has equity capital of Rs 11.44 crore. Face value per share is Rs 10.

Venus Remedies reported net loss of Rs 2.10 crore in Q3 December 2016 as against net loss of Rs 0.25 crore in Q3 December 2015. Net sales declined 12.61% to Rs 84.49 crore in Q3 December 2016 over Q3 December 2015.

Venus Remedies is a pharmaceutical company.

Powered by Capital Market - Live News

HDFC Bank leads gainers on BSEs A group
Feb 17,2017

HDFC Bank rose 7.05% at Rs 1,420.90. The stock topped the gainers in A group. On the BSE, 42.98 lakh shares were traded on the counter so far as against the average daily volumes of 65,000 shares in the past two weeks.

VA Tech Wabag rose 5.24% at Rs 520.50. The stock was the second biggest gainer in A group. On the BSE, 38,000 shares were traded on the counter so far as against the average daily volumes of 6,277 shares in the past two weeks.

Dewan Housing Finance Corporation rose 4.65% at Rs 318.75. The stock was the third biggest gainer in A group. On the BSE, 4.49 lakh shares were traded on the counter so far as against the average daily volumes of 2.50 lakh shares in the past two weeks.

Repco Home Finance rose 4.69% at Rs 662.45. The stock was the fourth biggest gainer in A group. On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 21,000 shares in the past two weeks.

Cadila Healthcare rose 4.32% at Rs 448. The stock was the fifth biggest gainer in A group. On the BSE, 9.67 lakh shares were traded on the counter so far as against the average daily volumes of 1.51 lakh shares in the past two weeks.

Powered by Capital Market - Live News